Instrument Inactif

Communiqués Inspyr Therapeutics Inc OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

2023	Rebus Holdings, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023	CI
2023	Rebus Holdings, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	21/11/22	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	16/11/22	AQ
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	13/10/22	AQ
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	12/08/22	PU
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	12/08/22	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	13/05/22	AQ
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/22	AQ
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	12/11/21	AQ
Inspyr Therapeutics : Material Event - Form 8-K/A	12/10/21	PU
INSPYR THERAPEUTICS : Form 8-K	12/10/21	PU
INSPYR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	12/10/21	AQ
Inspyr Therapeutics : AGREEMENT AND PLAN OF MERGER (Form 8-K)	05/10/21	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	05/10/21	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	16/08/21	AQ
Inspyr Therapeutics : SENIOR CONVERTIBLE DEBENTURE DUE JUNE 18, 2022 (Form 8-K)	21/06/21	PU
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21/06/21	AQ
Inspyr Therapeutics : NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN	17/05/21	AQ
INSPYR THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/21	AQ
INSPYR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	12/01/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Inspyr Therapeutics Inc OTC Bulletin Board

Actions

Communiqués

Filtres